Cancer biology in diabetes update: Focusing on antidiabetic drugs

被引:1
作者
Kawakita, Emi [1 ]
Kanasaki, Keizo [1 ,2 ]
机构
[1] Shimane Univ, Fac Med, Dept Internal Med 1, Izumo, Japan
[2] Shimane Univ, Fac Med, Ctr Integrated Kidney Res & Adv, Izumo, Japan
基金
日本学术振兴会;
关键词
Antidiabetic drugs; Cancer; Diabetes; GLUCAGON-LIKE PEPTIDE-1; RANDOMIZED PHASE-II; ACTING INSULIN ANALOGS; ALL-CAUSE MORTALITY; BLADDER-CANCER; COLORECTAL-CANCER; CARDIOVASCULAR OUTCOMES; PANCREATIC-CANCER; BREAST-CANCER; PIOGLITAZONE USE;
D O I
10.1111/jdi.14152
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The association of type 2 diabetes with certain cancer risk has been of great interest for years. However, the effect of diabetic medications on cancer development is not fully understood. Prospective clinical trials have not elucidated the long-term influence of hypoglycemic drugs on cancer incidence and the safety for cancer-bearing patients with diabetes, whereas numerous preclinical studies have shown that antidiabetic drugs could have an impact on carcinogenesis processes beyond the glycemic control effect. Because there is no evidence of the safety profile of antidiabetic agents on cancer biology, careful consideration would be required when prescribing any medicines to patients with diabetes and existing tumor. In this review, we discuss the potential influence of each diabetes therapy in cancer 'initiation', 'promotion' and 'progression'. The long-term influence of antidiabetic drugs use on cancer biology is not fully elucidated. We summarize and discuss the potential influence of each diabetes therapy in cancer 'initiation', 'promotion' and 'progression'. image
引用
收藏
页码:525 / 540
页数:16
相关论文
共 187 条
[81]   PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial [J].
Kitson, Sarah J. ;
Maskell, Zoe ;
Sivalingam, Vanitha N. ;
Allen, Jennifer L. ;
Ali, Saad ;
Burns, Sean ;
Gilmour, Kyle ;
Latheef, Rahamatulla ;
Slade, Richard J. ;
Pemberton, Philip W. ;
Shaw, Joseph ;
Ryder, W. David ;
Kitchener, Henry C. ;
Crosbie, Emma J. .
CLINICAL CANCER RESEARCH, 2019, 25 (08) :2424-2432
[82]   Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial [J].
Kordes, Sil ;
Pollak, Michael N. ;
Zwinderman, Aeilko H. ;
Mathot, Ron A. ;
Weterman, Mariette J. ;
Beeker, Aart ;
Punt, Cornelis J. ;
Richel, Dick J. ;
Wilmink, Johanna W. .
LANCET ONCOLOGY, 2015, 16 (07) :839-847
[83]  
Kubota T, 1998, CANCER RES, V58, P3344
[84]   Pioglitazone use and the risk of bladder cancer [J].
Kuo, Hsin-Wei ;
Tiao, Mao-Meng ;
Ho, Shu-Chen ;
Yang, Chun-Yuh .
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2014, 30 (02) :94-97
[85]   Cellular and Molecular Mechanisms of Metformin Action [J].
LaMoia, Traci E. ;
Shulman, Gerald, I .
ENDOCRINE REVIEWS, 2021, 42 (01) :77-96
[86]   The Association of Pioglitazone and Urinary Tract Disease in Type 2 Diabetic Taiwanese: Bladder Cancer and Chronic Kidney Disease [J].
Lee, Mei-Yueh ;
Hsiao, Pi-Jung ;
Yang, Yi-Hsin ;
Lin, Kun-Der ;
Shin, Shyi-Jang .
PLOS ONE, 2014, 9 (01)
[87]   Randomized phase II study of platinum-based chemotherapy plus controlled diet with or without metformin in patients with advanced non-small cell lung cancer [J].
Lee, Youngjoo ;
Joo, Jungnam ;
Lee, You Jin ;
Lee, Eun Kyung ;
Park, Sohyun ;
Kim, Tae-Sung ;
Lee, Soo-Hyun ;
Kim, So Young ;
Wie, Gyung-Ah ;
Park, Minjoung ;
Kim, Mi-Jung ;
Lee, Jin Soo ;
Han, Ji-Youn .
LUNG CANCER, 2021, 151 :8-15
[88]   Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial [J].
Leiter, L. A. ;
Teoh, H. ;
Mosenzon, O. ;
Cahn, A. ;
Hirshberg, B. ;
Stahre, C. A. M. ;
Hoekstra, J. B. L. ;
Alvarsson, M. ;
Im, K. ;
Scirica, B. M. ;
Bhatt, D. L. ;
Raz, I. .
DIABETES OBESITY & METABOLISM, 2016, 18 (02) :186-190
[89]   Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis [J].
Levin, Daniel ;
Bell, Samira ;
Sund, Reijo ;
Hartikainen, Sirpa A. ;
Tuomilehto, Jaakko ;
Pukkala, Eero ;
Keskimaki, Ilmo ;
Badrick, Ellena ;
Renehan, Andrew G. ;
Buchan, Iain E. ;
Bowker, Samantha L. ;
Minhas-Sandhu, Jasjeet K. ;
Zafari, Zafar ;
Marra, Carlo ;
Johnson, Jeffrey A. ;
Stricker, Bruno H. ;
Uitterlinden, Andre G. ;
Hofman, Albert ;
Ruiter, Rikje ;
de Keyser, Catherine E. ;
MacDonald, Thomas M. ;
Wild, Sarah H. ;
McKeigue, Paul M. ;
Colhoun, Helen M. .
DIABETOLOGIA, 2015, 58 (03) :493-504
[90]   Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes [J].
Lewis, James D. ;
Habel, Laurel A. ;
Quesenberry, Charles P. ;
Strom, Brian L. ;
Peng, Tiffany ;
Hedderson, Monique M. ;
Ehrlich, Samantha F. ;
Mamtani, Ronac ;
Bilker, Warren ;
Vaughn, David J. ;
Nessel, Lisa ;
Van Den Eeden, Stephen K. ;
Ferrara, Assiamira .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (03) :265-277